Alcon Operating Margin 2019-2022 | ALC

Current and historical operating margin for Alcon (ALC) over the last 10 years. The current operating profit margin for Alcon as of September 30, 2022 is 13.50%.
Alcon Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-09-30 $8.70B $0.83B 9.58%
2022-06-30 $8.66B $0.65B 7.49%
2022-03-31 $8.55B $0.68B 7.92%
2021-12-31 $8.29B $0.58B 7.00%
2021-09-30 $8.08B $0.54B 6.67%
2021-06-30 $7.82B $0.39B 4.99%
2021-03-31 $6.92B $-0.31B -4.41%
2020-12-31 $6.83B $-0.48B -7.05%
2020-09-30 $6.81B $-0.69B -10.15%
2020-06-30 $6.84B $-0.58B -8.48%
2020-03-31 $7.53B $-0.17B -2.22%
2019-12-31 $7.51B $-0.19B -2.49%
2019-06-30 $5.49B $-0.39B -7.01%
2019-03-31 $5.41B $-0.29B -5.44%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.369B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00